BSEInsider Trading / SAST22h ago · 30 Oct 2026, 05:38 pm

Trading Window Closure Under SEBI (Prohibition of Insider Trading) Regulations, 2015

Medplus Health Services Ltd · 543427

✦ AI Summaryinsider_trading

Medplus Health Services Ltd has announced the closure of its trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of a Board meeting to consider a proposal for buying back its equity shares. The trading window will be closed from October 30, 2026, until 48 hours after the outcome of the Board meeting is made public. The company has also informed that the Board meeting will be held on November 06, 2026, to consider the buy-back proposal and related matters.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Medplus Health Services Ltd - 543427 - Closure of Trading Window

Attachments (1)

📄

bbf09b0d-d474-4072-b3a0-12bd8e2f2346.pdf

pdf

Download →
View document text
MedPlus Health Services Limited October 30, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Mumbai 400 001 Bandra (East), Mumbai – 400 051 BSE Scrip Code Equity: 543427 NSE Symbol: MEDPLUS Dear Sir/ Madam, Sub: Intimation of Board Meeting to consider Buy-back of equity shares Ref.: Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR ") and Trading Window Closure under SEBI (Prohibition of Insider Trading) Regulations, 2015. Pursuant to Regulation 29 of the SEBI LODR, we would like to inform that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 06, 2026, to consider, inter- alia, a proposal of buy back of the fully paid-up equity shares of the Company including matters related/incidental thereto in accordance with the provisions of Sections 68, 69, and 70 of the Companies Act, 2013, read with rules made thereto and the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company’s Code of Conduct for Prevention of Insider Trading, the trading window for the Designated Persons of the Company and including their immediate relatives, will be closed from Friday, 30 October 2026, till 48 hours after the outcome of the Board Meeting in relation to the proposal for buy back of the fully paid-up equity shares of the Company, is made public. The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. Thanking You Yours faithfully For MedPlus Health Services Limited Shrenik Soni Company Secretary & Compliance Officer ICSI M. No. F12400 040-6724 6724 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com